Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockade

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 5, 2007, Pages

  Goddard, Jane ^a   Johnston, Neil R ^a   Cumming, Allan D ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Human; Kidney

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; URINALYSIS; URINARY EXCRETION;

EID: 36048946080     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00101.2007     Document Type: Article

References (27)

1. Anonymous. NKF K/DOQI Guidelines. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. PART 4. Definition and classification of stages of Chronic Kidney Disease. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/ p4_class_g1.htm [September 2007].
2. Benigni A, Perico N, Gaspari F, Zoja C, Bellizzi M, Gabanelli M, Remuzzi G. Increased renal endothelin production in rats with reduced renal mass. Am J Physiol Renal Fluid Electrolyte Physiol 260: F331-F339, 1991.
3. Burkhart M, Barton M, Shaw SG. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA blockade. J Hypertens 18: 273-279, 2000.
4. Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 81: 1510-1515, 1996.
5. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1278-1284, 1996.
6. Gasic S, Wagner OF, Vierhapper H, Nowotny P, Waldhausl W. Regional haemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to overall disposal of the peptide. J Cardiovasc Pharmacol 19: 176-180, 1992.
7. Gekle M, Mildenberger S, Freudinger R, Silbernagl S. Long-term protein exposure reduces albumin binding and uptake in proximal tubule-derived opossum kidney cells. J Am Soc Nephrol 9: 960-968, 1998.
8. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation 109: 1186-1193, 2004.
9. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T, Suda H, Yano M. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 20, Suppl 12: S11-S14, 1992.
10. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin Breceptor antagonist, BQ-788. Proc Nat Acad Sci USA 91: 4892-4896, 1994.
11. Karet F, Kuc R, Davenport A. Novel ligands BQ 123 and BQ 3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int 44: 36-42, 1993.
12. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet 8645: 991-992, 1989.
13. Masereeuw R, Terlouw SA, van Aubel RA, Russke FG, Miller DS. Endothelin B receptor mediated regulation of ATP-driven drug secretion in renal proximal tubule. Mol Pharmacol 57: 59-67, 2000.
14. Notenboom S, Miller DS, Smits P, Russel FG, Masereeuw R. Role of NO in endothelin-regulated drug transport in the renal proximal tubule. Am J Physiol Renal Physiol 282: F458-F464, 2002.
15. Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, Marumo F. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39: 307-311, 1991.
16. Rolinski B, Bonger SJ, Goebel FD. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res Exp Med 194: 9-24, 1994.
17. Saito Y, Kazuwa N, Shirakami G, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y, Imura H. Endothelin in patients with chronic renal failure. J Cardiovasc Pharmacol 17, Suppl 7: S437-S439, 1991.
18. Serneri GGN, Modesti PA, Cecioni I, Biagini D, Migliorini A, Costolo A, Colella A, Naldoni A, Paoletti P. Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am J Physiol Heart Circ Physiol 268: H1829-H1837, 1995.
19. Strachan FE, Spratt JC, Wilkinson IB, Johnston N, Gray GA, Webb DJ. Systemic blockade of the endothelin-B receptor increases peripheral resistance in healthy men. Hypertension 33: 581-585, 1999.
20. Spratt JCS, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134: 648-654, 2001.
21. Suga S, Yasui N, Yoshihara F, Horio T, Kawano Y, Kangawa K, Johnson RJ. Endothelin A receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms. J Am Soc Nephrol 14: 397-406, 2003.
22. Taylor TA, Gariepy CE, Pollock DM, Pollock JS. Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet. Hypertension 41: 657-662, 2003.
23. Vlachojannis J, Tsakas S, Petropoulou C, Kurz P. Increased renal excretion of endothelin-1 in nephrotic patients. Nephrol Dial Transplant 12: 470-473, 1997.
24. Wesson DE. Endogenous endothelins mediate increased acidification in remnant kidneys. J Am Soc Nephrol 12: 1826-1835, 2001.
25. Worgall S, Manz F, Kleschin K, Rascher W. Elevated urinary excretion of endothelin-like immunoreactivity in children with renal disease is related to urine flow rate. Clin Nephrol 41: 331-337, 1994.
26. Zeiler M, Loffler BM, Bock HA, Thiel G. ET-1 excretion is urine flow-dependent in kidney donors and transplant recipients. J Cardiovasc Pharmacol 26, Suppl 3: S513-S515, 1995.
27. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26: 934-941, 1995.